There are only a month, yet the news was reassuring. The second patient who received an artificial heart designed by CARMAT died on May 2, announced Monday the French company in a statement, confirming a report by Libération . He was hospitalized in Nantes Friday, May 1 in the evening after circulatory failure. “A functional the prosthesis drift” was found. A new heart was then implanted but the patient had postoperative complications.
The man of 69 years had been operated for the first time on August 5 at the University Hospital of Nantes (Loire-Atlantique). So it has survived almost nine months with the artificial heart. In an interview with JDD in April, however, he said is “feel revived.” His doctor even told that his patient had resumed physical activity and saluted his progress. “His day is that of us all,” thus affirmed the specialist in that time.
A third patient implanted
CARMAT also confirmed the implementation of his artificial heart in a third patient on April 28, as part of a feasibility trial, which must include a total of four heart failure patients whose life is involved shortly. “The company is currently conducting data analysis of the prosthesis in accordance with the clinical trial protocol, to identify the possible causes of death and to ensure maximum safety for the third patient implanted,” said the company in a statement. The success criteria include among others the survival at 30 days after implantation and functional recovery of vital organs.
The first carrier CARMAT artificial heart, Claude Dany, 76, was also died March 2, 2014, 74 days after implantation.
& gt; & gt; Video: Should we see in this new death a failure of CARMAT prosthesis? Analysis of the cardiologist Olivier Hoffman
No comments:
Post a Comment